In HCC, the varying degrees of activity of glucose-6-phosphatase and glucose transporters, as well as the degree of differentiation, result in variable accumulation of FDG [21,24,25], thus limiting the diagnostic accuracy of FDG PET in the evaluation of HCC. The gene discussed is G6PC1; the disease is hepatocellular carcinoma.